EUVIMEDEUVIMED entdecken
Vergleichsstudie

Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes

Dilara Altun, Emine Esra Karaca, Mehmet Önen, Öznur Bekmez, Özlem Evren Kemer

International Ophthalmology · 2026

DOI: 10.1007/s10792-026-04223-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Ophthalmology, 2026. Verfasst von Dilara Altun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye. drdilara.altun@gmail.com. Hauptthemen laut MEDLINE: Visual Acuity, Descemet Stripping Endothelial Keratoplasty, Vitrectomy, Corneal Diseases. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare visual, anatomic, and graft-related outcomes after Descemet membrane endothelial keratoplasty (DMEK) in vitrectomized versus non-vitrectomized eyes, and to identify factors associated with adverse outcomes in these eyes.

Methods

This retrospective study analyzed DMEK performed between January 2018 and January 2025. Fifty-four vitrectomized eyes with pseudophakic bullous keratopathy (PBK) were compared with 50 non-vitrectomized PBK controls without major ocular comorbidity. Outcomes included best-corrected visual acuity (BCVA), central corneal thickness (CCT), endothelial cell density (ECD) and ECD loss, graft-related reinterventions, and cystoid macular edema (CME).

Results

104 eyes were analyzed. BCVA and CCT improved significantly in both groups (p < 0.001). At 12 months, vitrectomized eyes had lower ECD (1458 ± 545 vs 1759 ± 436 cells/mm^2; p = 0.030) and greater ECD loss (50.8 ± 18.6% vs 38.5 ± 15.2%; p = 0.031). CME (35.2% vs 6.0%; p < 0.001) and repeat DMEK (20.4% vs 4.0%; p = 0.016) were more frequent in vitrectomized eyes. Rebubbling (29.6% vs 16.0%) and penetrating keratoplasty (7.4% vs 0%) were more common but nonsignificant (p = 0.11, 0.12). A longer vitrectomy-to-DMEK interval was associated with CME (p = 0.013).

Conclusion

DMEK provides meaningful visual and anatomic improvement in vitrectomized eyes. However, versus controls they had greater endothelial cell loss, more frequent repeat DMEK, and markedly higher CME, whereas rebubbling and penetrating keratoplasty differences were nonsignificant. Given their heterogeneity, frequent capsular–zonular compromise, and the retrospective design, these associations warrant caution. Vitrectomized eyes represent a complex, higher-risk DMEK group warranting closer follow-up and individualized perioperative management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Visual AcuityDescemet Stripping Endothelial KeratoplastyVitrectomyCorneal DiseasesPostoperative ComplicationsHumansRetrospective StudiesFemaleMaleAgedGraft SurvivalReoperationFollow-Up StudiesMacular EdemaMiddle AgedCell CountEndothelium, Corneal

Stichwörter der Autor:innen

Cystoid macular edemaDescemet membrane endothelial keratoplastyEndothelial cell densityGraft survivalPseudophakic bullous keratopathyVitrectomized eyes

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye. drdilara.altun@gmail.com.
  • Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye.

Zitieren

APA

Altun, D., Karaca, E. E., Önen, M., Bekmez, Ö., & Evren Kemer, Ö. (2026). Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes. International Ophthalmology. https://doi.org/10.1007/s10792-026-04223-3

Vancouver

Altun D, Karaca EE, Önen M, Bekmez Ö, Evren Kemer Ö. Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes. International Ophthalmology. 2026. doi:10.1007/s10792-026-04223-3

BibTeX
@article{Altun2026,
  author = {Altun, Dilara and Karaca, Emine Esra and Önen, Mehmet and Bekmez, Öznur and Evren Kemer, Özlem},
  title = {Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes},
  journal = {International Ophthalmology},
  year = {2026},
  doi = {10.1007/s10792-026-04223-3}
}
Kostenlos starten →